Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression
Frontiers in Oncology · 05.08.2026 · 16
DOI: 10.3389/fonc.2026.1900337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 05.08.2026. Verfasst von Jakub Klekowski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, 4th Military Clinical Hospital, Wroclaw, Poland. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) remains one of the major challenges in contemporary oncology. Despite advances in imaging diagnostics and histopathological assessment, we still lack tools for the early detection of micrometastases and molecular alterations. The purinergic and endocannabinoid systems play an important role in CRC pathogenesis, yet their mutual interactions are not fully understood.
Methods
The study involved serum samples from 117 patients undergoing CRC surgical treatment. We performed targeted serum metabolomic profiling of purine metabolites and endocannabinoid-related lipids. Advanced statistical modeling (elastic-net regression and stepwise selection) was applied to link metabolite concentrations with TNM stage and pathological features, such as neuroinvasion and vascular infiltration.
Results
AMP was the strongest marker positively correlated with higher TNM stage. On the other hand, 2-AG level showed consistent negative correlation with neuroinvasion and lymphatic nodes metastasis. Xanthine level and N stage correlation was also observed.
Conclusions
The results allow us to propose a model in which AMP and 2-AG constitute opposing poles of the metabolic profile in CRC patients An increase in serum AMP was associated with more advanced CRC stage, whereas lower 2-AG levels were associated with invasive features, particularly neuroinvasion. This suggests that altered purine/nucleotide metabolism may be associated with reduced endocannabinoid tone in advanced CRC. However, the proposed interaction between purinergic signalling, COX-2 activity and 2-AG metabolism should be interpreted as a hypothesis-generating model requiring direct tissue-level validation. These findings support further investigation of purine–endocannabinoid crosstalk as a potential biologically relevant pathway in CRC progression, but therapeutic implications require direct tissue-level and functional validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, 4th Military Clinical Hospital, Wroclaw, Poland.
- Division of Anesthetic and Surgical Nursing, Department of Nursing, Faculty of Nursing and Midwifery, Wroclaw Medical University, Wroclaw, Poland.
- Omics Research Center, Wroclaw Medical University, Wroclaw, Poland.
- Department of Clinical Surgical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.
- Department of Biochemistry and Immunochemistry, Wroclaw Medical University, Wroclaw, Poland.
- Department of Oncological Surgery, Research and Development Centre at Regional Specialist Hospital, Wroclaw, Poland.
Zitieren
APA
Klekowski, J., Fortuna, P., Chabowski, M., Lewandowski, Ł., Szewczak, W., Mosna, K., Maciejewska, G., Zawadzki, M., Krzystek-Korpacka, M., & Fleszar, M. (2026). Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1900337
Vancouver
Klekowski J, Fortuna P, Chabowski M, Lewandowski Ł, Szewczak W, Mosna K, et al. Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1900337
BibTeX
@article{Klekowski2026,
author = {Klekowski, Jakub and Fortuna, Paulina and Chabowski, Mariusz and Lewandowski, Łukasz and Szewczak, Wioleta and Mosna, Karolina and Maciejewska, Gabriela and Zawadzki, Marek and Krzystek-Korpacka, Małgorzata and Fleszar, Mariusz},
title = {Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1900337}
}
EUVIMED